HCPCS Code Descriptor:
Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
66302-0206-03, 66302-0206-04, 66302-0206-02, 66302-0206-01
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
TYVASO is a Cardiology drug manufactured by United Therapeutics and administered via the Inhalation route of administration. The J Code: J7686 is aligned to the drug TYVASO.